{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:17:50Z","timestamp":1785896270578,"version":"3.56.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1006\/taap.2001.9167","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T22:01:25Z","timestamp":1032386485000},"page":"89-98","source":"Crossref","is-referenced-by-count":78,"title":["Protection of the Cyp1a2(\u2212\/\u2212) Null Mouse against Uroporphyria and Hepatic Injury Following Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin"],"prefix":"10.1006","volume":"173","author":[{"given":"Andrew G.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Clothier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Carthew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Nebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/taap.2001.9167_RF1","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1074\/jbc.275.4.2295","article-title":"Uroporphyrinogen III synthase. An alternative promoter controls erythroid-specific expression in the murine gene","volume":"275","author":"Aizencang","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1006\/taap.2001.9167_RF2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00008571-199812000-00005","article-title":"Chromosomal linkage analysis of porphyria in mice induced by hexachlorobenzene-iron synergism: A model of sporadic porphyria cutanea tarda","volume":"8","author":"Akhtar","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1006\/taap.2001.9167_RF3","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/hep.510270627","article-title":"Porphyria cutanea tarda, hepatitis C and HFE gene mutations in North America","volume":"27","author":"Bonkovsky","year":"1998","journal-title":"Hepatology"},{"key":"10.1006\/taap.2001.9167_RF4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jama.1963.03700020038009","article-title":"Acquired toxic porphyria cutanea tarda due to hexachlorobenzene","volume":"183","author":"Cam","year":"1963","journal-title":"JAMA"},{"key":"10.1006\/taap.2001.9167_RF5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-4274(84)90149-8","article-title":"In vitro inhibitory effet on porphyrinogen carboxylyase of liver extracts from TCDD treated mice","volume":"20","author":"Cantoni","year":"1984","journal-title":"Toxicol. Lett."},{"key":"10.1006\/taap.2001.9167_RF6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s004390000415","article-title":"Association of CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda","volume":"107","author":"Christiansen","year":"2000","journal-title":"Hum. Genet."},{"key":"10.1006\/taap.2001.9167_RF7","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0006-2952(96)00475-3","article-title":"Uroporphyria induced by 5-aminolevulinic acid in Ahrd SWR mice","volume":"52","author":"Constantin","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2559.1980.tb02942.x","article-title":"The pathology of the liver n porphyria cutanea tarda","volume":"4","author":"Cortes","year":"1980","journal-title":"Histopathology"},{"key":"10.1006\/taap.2001.9167_RF9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/bbrc.1999.1913","article-title":"Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery","volume":"267","author":"Dalton","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/taap.2001.9167_RF10","first-page":"463","article-title":"Role of iron in the hydrogen peroxide-dependent oxidation of hexahydro porphyrins (porphyrinogens): A possible mechanism for the exacerbation by iron of hepatic uroporphyria","volume":"33","author":"De Matteis","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0738-081X(97)00206-X","article-title":"Porphyria cutanea tarda of the toxic and sporadic varieties","volume":"16","author":"De Matteis","year":"1998","journal-title":"Clin. Dermatol."},{"key":"10.1006\/taap.2001.9167_RF12","first-page":"103","article-title":"DNA reactions, mutagenic action, and stealth properties of polycyclic aromatic hydrocarbon carcinogens","volume":"14","author":"Dipple","year":"1999","journal-title":"Int. J. Oncol."},{"key":"10.1006\/taap.2001.9167_RF13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00008571-199510000-00001","article-title":"Role of cytochrome P450 1A2 in chemical carcinogenesis: Implications for human variability in expression and enzyme activity","volume":"5","author":"Eaton","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1006\/taap.2001.9167_RF14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-2007-1007142","article-title":"Porphyria cutanea tarda","volume":"18","author":"Elder","year":"1998","journal-title":"Semin. Liver Dis."},{"key":"10.1006\/taap.2001.9167_RF15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0006-291X(82)91573-X","article-title":"Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzene","volume":"109","author":"Elder","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/taap.2001.9167_RF16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(85)90287-9","article-title":"Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda","volume":"1","author":"Elder","year":"1985","journal-title":"Lancet"},{"key":"10.1006\/taap.2001.9167_RF17","doi-asserted-by":"crossref","unstructured":"Fernandez-Salguero, P. M., Hilbert, D. M., Rudikoff, S., Ward, J. M., and Gonzalez, F. J.1996. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol.140, 173\u2013179.","DOI":"10.1006\/taap.1996.0210"},{"key":"10.1006\/taap.2001.9167_RF18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-291X(87)90683-8","article-title":"Polycyclic hydrocarbons cause hepatic porphyria in iron loaded C57BL\/10ScSn mice: Comparision of uroporphyrinogen decarboxylase inhibition with induction of alkoxyphenoxazone dealkylation","volume":"146","author":"Francis","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/taap.2001.9167_RF19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0014-5793(88)80449-6","article-title":"Oxidation of uroporphyrinogens by hydroxyl radicals: Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase","volume":"733","author":"Francis","year":"1988","journal-title":"FEBS Lett."},{"key":"10.1006\/taap.2001.9167_RF20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0006-2952(99)00088-X","article-title":"Role of small difference in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL\/6 and SWR strains of mice","volume":"50","author":"Gorman","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0304-4165(80)90163-4","article-title":"Studies of porphyrin synthesis in fibroblasts of patients with congenital erythropoietic porphyria and one patient with homozygous porphyria","volume":"629","author":"Grandchamp","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1006\/taap.2001.9167_RF22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0041-008X(84)90265-5","article-title":"Incomplete correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin hepatotoxicity with Ah phenotype in mice","volume":"74","author":"Greig","year":"1984","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF23","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0006-2952(98)00241-X","article-title":"Methoxyresorufin: An inappropriate substrate for CYP1A2 in the mouse","volume":"56","author":"Hamm","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.pa.35.040195.001515","article-title":"The aryl hydrocarbon receptor complex","volume":"35","author":"Hankinson","year":"1995","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1006\/taap.2001.9167_RF25","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0140-6736(93)90562-U","article-title":"Is hepatitis C virus infection a trigger for porphyria cutanea tarda?","volume":"341","author":"Herro","year":"1993","journal-title":"Lancet"},{"key":"10.1006\/taap.2001.9167_RF26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1006\/bbrc.1996.0637","article-title":"The heme-responsive element of the mouse heme oxygenase gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors","volume":"221","author":"Inamdar","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/taap.2001.9167_RF27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/bj2580247","article-title":"Oxidation of uroporphyrinogen by methylcholanthrene-induced cytochrome P450","volume":"258","author":"Jacobs","year":"1989","journal-title":"Biochem. J."},{"key":"10.1006\/taap.2001.9167_RF28","first-page":"328","article-title":"Chlorakne Porphyria Cutanea Tarda und andere Intoxikationen durch herbizide","volume":"27","author":"Jirasek","year":"1976","journal-title":"Hautarzt"},{"key":"10.1006\/taap.2001.9167_RF29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0041-008X(91)90145-5","article-title":"Disposition of 2,3,7,8-tetrabromodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat: Biliary excretion and induction of cytochromes CYP1A1 and CYP1A2","volume":"111","author":"Kedderis","year":"1991","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0045-6535(86)90039-1","article-title":"High affinity of 2,3,4,7,8-pentachlorodibenzofuran to cytochrome P-450 in the hepatic microsomes of rats","volume":"15","author":"Kuroki","year":"1986","journal-title":"Chemosphere"},{"key":"10.1006\/taap.2001.9167_RF31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0003-9861(92)90717-B","article-title":"Uroporphyrinogen oxidation catalyzed by reconstituted cytochrome P450 1A2","volume":"294","author":"Lambrecht","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1006\/taap.2001.9167_RF32","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0006-2952(97)00263-3","article-title":"Sensitivity of CYP1A1 mRNA inducibility by dioxin is the same in Cypla2(+\/+) wild-type and Cypla2(\u2212\/\u2212) null mutant mice","volume":"54","author":"Liang","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF33","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1073\/pnas.93.4.1671","article-title":"Cypla2(\u2212\/\u2212) null mutant mice develop normally but show deficient drug metabolism","volume":"93","author":"Liang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/taap.2001.9167_RF34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/taap.1996.0009","article-title":"Modulation by iron of hepatic microsomal and nuclear cytochrome P450, and cytosolic glutathione S-transferase and peroxidase in C57BL\/10ScSn mice induced with polychlorinated biphenyls (Aroclor 1254)","volume":"136","author":"Madra","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF35","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0016-5085(99)70464-6","article-title":"Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria","volume":"177","author":"Meerman","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1006\/taap.2001.9167_RF36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/dna.1996.15.273","article-title":"Human drug-metabolizing enzyme polymorphisms: Effects on risk of toxicity and cancer","volume":"15","author":"Nebert","year":"1996","journal-title":"DNA Cell Biol."},{"key":"10.1006\/taap.2001.9167_RF37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1749-6632.2000.tb06876.x","article-title":"\u201cGene-swap knock-in\u201d cassette in mice to study allelic differences in human genes","volume":"919","author":"Nebert","year":"2000","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1006\/taap.2001.9167_RF38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-2952(99)00310-X","article-title":"Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis","volume":"59","author":"Nebert","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/enrs.1999.3983","article-title":"Persistent health effects of dioxin contamination in herbicide production","volume":"81","author":"Neuberger","year":"1999","journal-title":"Environ. Res. A"},{"key":"10.1006\/taap.2001.9167_RF40","unstructured":"Oscarson, M, Ingelman-Sundberg, M, Daly, A. K, and, Nebert, D. W. 2001, Human Cytochrome P450 (CYP) Alleles, http:\/\/www.imm.ki.se\/CYPalleles\/."},{"key":"10.1006\/taap.2001.9167_RF41","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1073\/pnas.93.6.2322","article-title":"Induction of cytochrome P450 1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2b)carbazole is associated with oxidative DNA damage","volume":"93","author":"Park","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/taap.2001.9167_RF42","first-page":"189","article-title":"Metabolism of polycyclic aromatic hydrocarbons: Etiologic role in carcinogenesis","volume":"34","author":"Pelkonen","year":"1982","journal-title":"Pharmacol. Rev."},{"key":"10.1006\/taap.2001.9167_RF43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1073\/pnas.98.1.259","article-title":"A mouse model of familial porphyria cutanea tarda","volume":"98","author":"Phillips","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/taap.2001.9167_RF44","first-page":"113","article-title":"[125I]2-Iodo-3,7,8-tetrachlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: Characterization and identification","volume":"36","author":"Poland","year":"1989","journal-title":"Mol. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF45","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0006-2952(99)00406-2","article-title":"Activation of transcription factors AP-1 and NF-kB by 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"59","author":"Puga","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(96)09436-6","article-title":"Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda","volume":"349","author":"Roberts","year":"1997","journal-title":"Lancet"},{"key":"10.1006\/taap.2001.9167_RF47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hep.510270128","article-title":"High prevalance of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda","volume":"27","author":"Sampietro","year":"1998","journal-title":"Hepatology"},{"key":"10.1006\/taap.2001.9167_RF48","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/mol.56.3.588","article-title":"Oxidative inactivation of cytochrome P-450 1A (CYP1A) stimulated by 3,3\u2032,4,4\u2032-tetrachlorobiphenyl: Production of reactive oxygen by vertebrate CYP1As","volume":"56","author":"Schlezinger","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.cellbio.12.1.55","article-title":"Ah receptor signaling pathways","volume":"12","author":"Schmidt","year":"1996","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1006\/taap.2001.9167_RF50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/bbrc.1998.9753","article-title":"Dioxin causes a sustained oxidative stress response in the mouse","volume":"253","author":"Shertzer","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/taap.2001.9167_RF51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0003-9861(90)90436-3","article-title":"Chlorinated biphenyls induce cytochrome P450 1A2 and uroporphyrin accumulation in cultures of mouse hepatocytes","volume":"281","author":"Sinclair","year":"1990","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1006\/taap.2001.9167_RF52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/bj3300149","article-title":"Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cypla2(\u2212\/\u2212) null mutant mice","volume":"330","author":"Sinclair","year":"1998","journal-title":"Biochem. J."},{"key":"10.1006\/taap.2001.9167_RF53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/taap.1999.8832","article-title":"CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron","volume":"162","author":"Sinclair","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF54","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/jhep.2001.21409","article-title":"Uroporphyria in Hfe mutant mice given 5-aminolevulinate: A new model of Fe-mediated porphyria cutanea tarda","volume":"33","author":"Sinclair","year":"2001","journal-title":"Hepatology"},{"key":"10.1006\/taap.2001.9167_RF55","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1042\/bj2140909","article-title":"Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice","volume":"214","author":"Smith","year":"1983","journal-title":"Biochem. J."},{"key":"10.1006\/taap.2001.9167_RF56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/bj2460221","article-title":"Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload","volume":"246","author":"Smith","year":"1987","journal-title":"Biochem J."},{"key":"10.1006\/taap.2001.9167_RF57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/bj2910029","article-title":"Genetic variations of iron-induced uroporphyria in mice","volume":"291","author":"Smith","year":"1993","journal-title":"Biochem. J."},{"key":"10.1006\/taap.2001.9167_RF58","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/0006-2952(81)90421-4","article-title":"Hepatic toxicity and uroporphyrinogen decarboxylase activity following a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin to mice","volume":"30","author":"Smith","year":"1981","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF59","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0378-4274(95)03530-3","article-title":"Synergy of iron in the toxicity and carcinogenicity of polychlorinated biphenyls (PCBs) and related chemicals","volume":"82","author":"Smith","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1006\/taap.2001.9167_RF60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1124\/mol.53.1.52","article-title":"Interaction between iron metabolism and 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice with variants of the Ahr gene: A hepatic oxidative mechanism","volume":"53","author":"Smith","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF61","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1126\/science.432648","article-title":"Iron deficiency prevents liver toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"204","author":"Sweeney","year":"1979","journal-title":"Science"},{"key":"10.1006\/taap.2001.9167_RF62","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/bj2530357","article-title":"Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid","volume":"253","author":"Urquhart","year":"1988","journal-title":"Biochem. J."},{"key":"10.1006\/taap.2001.9167_RF63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0041-008X(87)90307-3","article-title":"Specific binding of polyhalogenated aromatic hydrocarbon inducers of cytochrome P450d to the cytochrome and inhibition of its estradiol 2-hydroxylase activity","volume":"90","author":"Voorman","year":"1987","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.2001.9167_RF64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.pharmtox.39.1.103","article-title":"Induction of cytochrome P450 1A1","volume":"39","author":"Whitlock","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1006\/taap.2001.9167_RF65","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-2952(01)00568-8","article-title":"Role of cytochrome 1A2 in bilirubin degradation. Sudies in Cyp1a2(\u2212\/\u2212) mice","author":"Zaccaro","year":"2001","journal-title":"Biochem. Pharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X01991677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X01991677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:29:11Z","timestamp":1576542551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X01991677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S0041008X01991677"],"URL":"https:\/\/doi.org\/10.1006\/taap.2001.9167","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}